Minodronic acid

Minodronic acid (also known as minodronate, brand names Bonoteo and Recalbon) is a potent, third-generation nitrogen-containing bisphosphonate drug used mainly for the treatment of osteoporosis. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Minodronate and Onobis. Its PubChem CID is 130956.

CAS No 180064-38-4
Molecular Formula C9H12N2O7P2
Molecular Weight 322.15 g/mol
Synonyms (1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid

Frequently Asked Questions